Clinical trials
Diabetes Mellitus, Type 2 trials in Portugal with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 7 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidade do Porto | 4 |
| Universidade Nova de Lisboa | 2 |
| Associacao Protectora dos Diabeticos de Portugal | 1 |
| Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv | 1 |
| Egas Moniz - Cooperativa de Ensino Superior, CRL | 1 |
| Faculdade de Motricidade Humana | 1 |
| GT Metabolic Solutions, Inc. | 1 |
| Hospital de Sao Sebastiao | 1 |
| Instituto Politécnico de Bragança | 1 |
| Universidade do Algarve | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 16 |
| Obesity | 4 |
| Diabetes Complications | 1 |
| Diabetes Mellitus | 1 |
| Dyslipidemias | 1 |
| Glucose Intolerance | 1 |
| Hypertension | 1 |
| Hypoxia | 1 |
| Insulin Resistance | 1 |
| Metabolic Syndrome | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.